SEC Form 4 · accession 0001179110-19-002470
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Ryll
Officer — VP, Technical Operations
Period of report
Feb 22, 2019
Accepted (ET)
Feb 25, 2019 · 10:11 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Feb 22, 2018 | S | 11,495 | $5.60 | D | 87,184 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Weighted average price of shares sold.
- F2The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.